Form 4: Tenet Healthcare Director Sells Shares

Tenet Healthcare Corp. Director Nadja West sold 2,178 shares of common stock at a weighted average price of $197.47.

Summary

• Nadja West, a Director of Tenet Healthcare Corp. (THC), reported a sale of common stock.
• The transaction involved the disposition of 2,178 shares of common stock.
• The shares were sold on December 15, 2025, at a weighted average sales price of $197.47 per share.
• The sales occurred in multiple transactions with prices ranging from $197.47 to $197.57.
• Following this transaction, Nadja West beneficially owns 28,480 shares of Tenet Healthcare Corp. common stock directly.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 5

Explanation: The filing is a factual disclosure of an insider transaction and does not inherently convey positive or negative sentiment about the company's performance or prospects. The sale is a routine disclosure under a 10b5-1 plan.

Negatives

• A director's sale of shares could be perceived as a slight negative signal by some investors, though the amount is relatively small.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing is a standard disclosure of an insider stock transaction and does not provide information directly related to broader industry trends or competitive landscape for the healthcare sector.

Stakeholder Impact

• Shareholders: Provides transparency regarding insider stock ownership changes, which can be a factor in investment decisions.

Key Dates

Keywords

Tenet Healthcare, THC, Insider Trading, Form 4, Stock Sale, Director Transaction, Nadja West, Rule 10b5-1